"controllo green pass"

During the past decade, Ospedale Santa Chiara conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 3 clinical trials were completed, i.e. on average, 10.3% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 2 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedale Santa Chiara" #1 sponsor was "National Cancer Institute, Naples" with 7 trials, followed by "European Institute of Oncology" with 2 trials sponsored, "Istituto Oncologico Veneto IRCCS" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "Mario Negri Institute for Pharmacological Research" with 2 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Santa Chiara" #1 collaborator was "Astellas Pharma Inc" with 2 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator, "University of Padova" with 2 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator and "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 31 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Santa Chiara" are "Ovarian Cancer" (4 trials), "Prostate Cancer" (3 trials), "Prostatic Neoplasms" (3 trials), "Breast Cancer" (2 trials) and "Acute Coronary Syndrome" (1 trials). Many other conditions were trialed in "Ospedale Santa Chiara" in a lesser frequency.

Most popular intervention types in "Ospedale Santa Chiara" are "Drug" (35 trials), "Biological" (7 trials), "Other" (7 trials), "Procedure" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Prednisone" (5 trials), "Docetaxel" (4 trials), "Enzalutamide" (3 trials) and "carboplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Santa Chiara" are 29 trials for "All" genders, 9 trials for "Male" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedale Santa Chiara". undefined are not yet recruiting, 4 are recruiting, 16 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Ospedale Santa Chiara, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Santa Chiara, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".

Ospedale Santa Chiara has several departments that took part in Clinical trials: "Ospedale Santa Chiara; Oncologia Medica" - 7 trials, "Ospedale Santa Maria Del Carmine - Cardiologia" - 4 trials, "Ospedale Santa Chiara, Divisione Di Cardiologia" - 3 trials, "Sezione di Ematologia - Med.II Div. Presidio Ospedaliero S. Chiara di Trento" - 2 trials, "Presidio Ospedaliaro Alto Gardo e Ledro" - 2 trials, "U.O. Radiologia, Ospedale Santa Chiara" - 2 trials, "UOC Chirurgia Generale 1 - Ospedale S. Chiara - APSS Trento" - 2 trials